Loading…

P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer

Highlights • Lip-DOPE-P5-MPL (DMPC/DMPG/Chol/DOPE/P5/MPL) is an effective peptide-based HER2/neu vaccine formulation. • Lip-DOPE-P5-MPL induces high IFN-γ production by CD8+ T cells intracellularly. • Lip-DOPE-P5-MPL induces CTL response leading to tumor growth inhibition. • Lip-DOPE-P5-MPL caused t...

Full description

Saved in:
Bibliographic Details
Published in:Cancer letters 2014-12, Vol.355 (1), p.54-60
Main Authors: Shariat, Sheida, Badiee, Ali, Jalali, Seyed Amir, Mansourian, Mercedeh, Yazdani, Mona, Mortazavi, Seyed Alireza, Jaafari, Mahmoud Reza
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • Lip-DOPE-P5-MPL (DMPC/DMPG/Chol/DOPE/P5/MPL) is an effective peptide-based HER2/neu vaccine formulation. • Lip-DOPE-P5-MPL induces high IFN-γ production by CD8+ T cells intracellularly. • Lip-DOPE-P5-MPL induces CTL response leading to tumor growth inhibition. • Lip-DOPE-P5-MPL caused the lowest tumor size and the longest survival time in mice model of TUBO tumor.
ISSN:0304-3835
1872-7980
DOI:10.1016/j.canlet.2014.09.016